05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
In a case where the jury found both the Architect and the Developer separately responsible for Plain...
Read More >
The Bank of New York Mellon v. Barber, Case No. 1D18-2097 (Fla. 1st DCA 2020). A trial judge may not...
Read More >
Joining the wave of jurisdictions limiting the competitive restraints employers may place on low-wag...
Read More >
Trucking companies will no longer need to pay their drivers for certain off-duty time, potentially i...
Read More >
To ensure the protection of the safety and health of employees, the French Supreme Court reiterated ...
Read More >
Waiting on Dorian to arrive or to skip Florida altogether got me thinking about the HR challenges of...
Read More >